Form 4 · Filed Jul 7, 2026, 11:50 PM UTC
NBP/NovaBridge Biosciences
Xu Cong Claire — SVP, Clinical Development
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | S | sell | 4,485 | $1 | $3,992 | 298,101 |
| Jul 4, 2026 | M | other | 12,432 | — | — | 302,586 |
| Jul 4, 2026 | M | other | 5,405 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0002114309-26-000005